These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 2526352

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Decrease in the number of rat brain dopamine and muscarinic receptors after chronic alcohol intake.
    Syvälahti EK, Hietala J, Röyttä M, Grönroos J.
    Pharmacol Toxicol; 1988 Apr; 62(4):210-2. PubMed ID: 3387375
    [Abstract] [Full Text] [Related]

  • 3. Muscarinic and dopaminergic receptor subtypes on striatal cholinergic interneurons.
    Dawson VL, Dawson TM, Wamsley JK.
    Brain Res Bull; 1990 Dec; 25(6):903-12. PubMed ID: 2149667
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats.
    Rupniak NM, Kilpatrick G, Hall MD, Jenner P, Marsden CD.
    Psychopharmacology (Berl); 1984 Dec; 84(4):512-9. PubMed ID: 6441952
    [Abstract] [Full Text] [Related]

  • 7. Effects of chronic treatment with selective and nonselective antagonists on the subtypes of dopamine receptors.
    McGonigle P, Boyson SJ, Reuter S, Molinoff PB.
    Synapse; 1989 Dec; 3(1):74-82. PubMed ID: 2521960
    [Abstract] [Full Text] [Related]

  • 8. Alteration in dopaminergic and muscarinic cholinergic receptors after subchronic treatment with haloperidol in the developing rat brain.
    Kajiyama H, Nomura Y.
    J Pharmacobiodyn; 1981 Feb; 4(2):85-90. PubMed ID: 7196947
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Binding of 3H-spiperone and 3H-(-)-sulpiride to dopamine D2 receptors in rat striatal membranes: methodological considerations and demonstration of the identical nature of the binding sites for the two ligands.
    Urwyler S, Coward D.
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Feb; 335(2):115-22. PubMed ID: 2951601
    [Abstract] [Full Text] [Related]

  • 12. Effects of Pro-Leu-Gly-NH2 and cyclo (Leu-Gly) on the binding of 3H-quinuclidinyl benzilate to striatal cholinergic muscarinic receptors.
    Das S, Matwyshyn GA, Bhargava HN.
    Peptides; 1986 Feb; 7(1):21-5. PubMed ID: 2872660
    [Abstract] [Full Text] [Related]

  • 13. Differential alteration of striatal D-1 and D-2 receptors induced by the long-term administration of haloperidol, sulpiride or clozapine to rats.
    Jenner P, Rupniak NM, Marsden CD.
    Psychopharmacology Suppl; 1985 Feb; 2():174-81. PubMed ID: 3159009
    [Abstract] [Full Text] [Related]

  • 14. [3H]spiperone and [3H]quinuclidinyl benzilate binding in striatal membranes from rats chronically treated with manganese chloride throughout development and for over two years.
    Leung TK, Lai JC, Lim L.
    Gen Pharmacol; 1986 Feb; 17(1):121-3. PubMed ID: 3949146
    [Abstract] [Full Text] [Related]

  • 15. Prevention of fluphenazine-induced changes in dopaminergic and muscarinic receptors by lithium.
    Gianutsos G, Friedman E.
    Pharmacol Biochem Behav; 1987 Mar; 26(3):635-7. PubMed ID: 3575380
    [Abstract] [Full Text] [Related]

  • 16. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
    Zahniser NR, Dubocovich ML.
    J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559
    [Abstract] [Full Text] [Related]

  • 17. Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions.
    List SJ, Seeman P.
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2620-4. PubMed ID: 6941314
    [Abstract] [Full Text] [Related]

  • 18. Effect of chronic administration of haloperidol (intermittently) and haloperidol-decanoate (continuously) on D2 dopamine and muscarinic cholinergic receptors and on carbachol-stimulated phosphoinositide hydrolysis in the rat striatum.
    Akiyama K, Sato M, Yamada N, Otsuki S.
    Jpn J Psychiatry Neurol; 1987 Jun; 41(2):311-20. PubMed ID: 2830427
    [Abstract] [Full Text] [Related]

  • 19. Effects of chronic administration of neuroleptic and anticholinergic agents on densities of D2 dopamine and muscarinic cholinergic receptors in rat striatum.
    Boyson SJ, McGonigle P, Luthin GR, Wolfe BB, Molinoff PB.
    J Pharmacol Exp Ther; 1988 Mar; 244(3):987-93. PubMed ID: 2908050
    [Abstract] [Full Text] [Related]

  • 20. Alterations in peripheral and central dopamine receptor sensitivity after subchronic treatment with fluphenazine and sulpiride.
    Hietala J, MacDonald E, Syvälahti E, Scheinin M.
    Pharmacol Toxicol; 1987 Jul; 61(1):48-52. PubMed ID: 3628181
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.